Jill Moormeier

621 citations
24 papers · 473 indexed · h-index 11
Topics
Lymphoma Diagnosis and Treatment (6 papers)Chronic Lymphocytic Leukemia Research (5 papers)Global Cancer Incidence and Screening (4 papers)

In The Last Decade

Jill Moormeier

24 papers receiving 460 citations

Peers

Jill Moormeier
Comparison fields: 5 of 77
  • Oncology 230
  • Pathology and Forensic Medicine 128
  • Surgery 80
  • Genetics 71
  • Cancer Research 50
Replace Helen Farrugia with:
Helen Farrugia Australia
Maria Koch Canada
Thomas Fietz Germany
Ruey-Kuen Hsieh Taiwan
Sabine Luttmann Germany
S. Rafla United States
Archie Bleyer United States
MM Hawkins United Kingdom
Brice Fresneau France
Sophie Tartas France
Jill Moormeier relative to Helen Farrugia Australia Helen Farrugia's profile →
Citations per field
00.5×2.5×
Helen Farrugia · 1×
Citations per year

Countries citing papers authored by Jill Moormeier

Since Specialization
Citations

This map shows the geographic impact of Jill Moormeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Moormeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Moormeier more than expected).

Fields of papers citing papers by Jill Moormeier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Moormeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Moormeier. The network helps show where Jill Moormeier may publish in the future.

Co-authorship network of co-authors of Jill Moormeier

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Moormeier. A scholar is included among the top collaborators of Jill Moormeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Moormeier. Jill Moormeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 5
3 5
4
The management of chronic diseases in rural Missouri practices.
2
5 29
6 7
7
Current issues in the diagnosis and management of deep vein thrombosis.
1
8 1
9 18
10 6
11 23
12 1
13 7
14 23
15
Mitoxantrone: potential for use in intensive therapy.
66
16
High-dose combination chemotherapy with thiotepa and autologous hematopoietic stem cell reinfusion in the treatment of patients with relapsed refractory lymphomas.
41
17 22
18 6
19 6
20 24

About Jill Moormeier

Jill Moormeier is a scholar working on Genetics, Oncology and Pathology and Forensic Medicine, having authored 24 papers that have together received 473 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Global Cancer Incidence and Screening (4 papers). The work is most often cited by research in Oncology (230 citations), Pathology and Forensic Medicine (128 citations) and Genetics (71 citations). Jill Moormeier has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Stephanie Williams, Nisreen Haideri, Rosemarie Mick, Harvey M. Golomb, Bitran Jd, Ralph R. Weichselbaum, Mark J. Ratain, Gerald W. Chodak, A. Awan and Harry W. Schoenberg. Their work appears in journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026